Matthew Garibaldi serves as an Associate Clinical Professor and as the Director of the Orthotic and Prosthetic Centers for the Department of Orthopaedic Surgery at UCSF. He oversees his division’s activities in patient care, research, and education.
In his research, Garibaldi investigates the validation of prosthetic assessment tools, formulates prosthetic patient preference surveys for regulatory purposes, and conducts quality of life outcomes research for experimental prosthetic technology.
Following a twenty-year clinical career, Garibaldi has played a key role in developing the Osseointegration program at UCSF and is the first prosthetist in the United States to treat patients using the transfemoral percutaneous osseointegration OPRA implant system.
Additionally, Garibaldi serves as the President of the California Orthotic and Prosthetic Association (COPA), he is a board-candidate for the American Academy of Orthotists and Prosthetists (AAOP), he is the creator of the Orthotic and Prosthetic Innovative Technologies (OPTech) conference, and a founding member of the Hospital-Based O&P Consortium.